SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3/A - Initial statement of beneficial ownership of securities: [Amend]
SEC Accession No. 0001683168-20-000182
Filing Date
2020-01-17
Accepted
2020-01-17 14:34:17
Documents
2
Period of Report
2019-12-30

Document Format Files

Seq Description Document Type Size
1 ownership.html 3/A  
1 ownership.xml 3/A 4569
2 POWER OF ATTORNEY neurobo_ex2401.htm EX-24.1 9451
  Complete submission text file 0001683168-20-000182.txt   15947
Mailing Address 12012 GATEWATER DR POTOMAC MD 20854
Business Address 12012 GATEWATER DR POTOMAC MD 20854 240-498-3852
JK BioPharma Solutions, Inc (Reporting) CIK: 0001590304 (see all company filings)

State of Incorp.: MD | Fiscal Year End: 1213
Type: 3/A | Act: 34 | File No.: 001-37809 | Film No.: 20533176

Mailing Address P.O. BOX 130235 ANN ARBOR MI 48113
Business Address P.O. BOX 130235 ANN ARBOR MI 48113 734-245-1700
NeuroBo Pharmaceuticals, Inc. (Issuer) CIK: 0001638287 (see all company filings)

IRS No.: 472389984 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address SEOLLEUNG-RO 206, #104-601 GANGNAM-GU SEOUL M5 06281
Business Address
Kang Sun Dae (Reporting) CIK: 0001799890 (see all company filings)

Type: 3/A | Act: 34 | File No.: 001-37809 | Film No.: 20533177